Src in cancer: deregulation and consequences for cell behaviour.

By M. Frame. Biochimica et Biophysica Acta, 2002

746 citations recorded by the source corpus.

Subfields: Molecular Biology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/2fc287e8d9bdbe4c13ab589ac79eb8dd75fc47e4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Timothy Yeatman
2. Ming Tan
3. Dihua Yu
4. J. Summy
5. G. Gallick

In Radiology, Nuclear Medicine and Imaging

1. Timothy Yeatman
2. J. Summy
3. G. Gallick

Citations in the corpus

• A renaissance for SRC (2004, background): “One potential explanation that has been offered for this apparent discrepancy is that c-SRC activation promotes growth during the process of tumorigenesis, but regulates other activities such as adhesion and invasion during the later stages of tumour progressio”
• Pathogenesis of Human Papillomaviruses in Differentiating Epithelia (2004, neutral): “with a variety of signaling networks (43).”
• PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. (2004, positive): “Thus, trastuzumab induces PTEN activation by (Frame, 2002).”
• Src family kinases in tumor progression and metastasis (2003, background): “These aspects have been reviewed extensively elsewhere [5,8], and will only be discussed briefly here.”